References in periodicals archive ?
The anti-CD20 monoclonal antibodies (mABs) market analysis considers sales from oncology, neurology, and immunology.
Despite tremendous advances in recombinant protein-expression level during the last decades, the development of the stable high-producing cell lines is still a major challenge, especially for more complex proteins such as monoclonal antibodies [14,15].
InNexus is a drug development company commercializing the next generation of monoclonal antibodies based on its DXL(TM) technology, which improves the potency of existing antibody products while opening new markets and disease applications.
What are monoclonal antibodies? They are produced by a mammalian cell that has been genetically engineered to produce specific antibodies, or proteins, that fight the disease state by attaching to a cell, such as a cancer cell.
For one thing, most trial volunteers who received monoclonal antibodies experienced unpleasant side effects.
The procedure allows one to obtain MESF values of biological cells stained with the same fluorophore-labeled monoclonal antibodies, the goal of the present study.
With the new monoclonal reagents, Herzenberg and his group rapidly extended the functional characterization of the mouse lymphocyte subsets and, when supplied by colleagues at the Sloan Kettering Institute with monoclonal antibodies to human lymphocyte surface antigens, identified the human homologs of the functional murine subsets.
Ruprecht uses monoclonal antibodies (pure antibodies produced by genetically modified cells) rather than serum or immunoglobulins prepared from serum, that deliver a variable mixture of many different antibodies.
Others were monoclonal antibodies, meaning they were clones (or exact copies) of unique antibodies created through biotechnology.
(JAD953) MONOCLONAL ANTIBODIES. JAY KIM of CHASE H&Q reviews the performance of the MONOCLONAL ANTIBODIES industry, and examines recent changes that have impacted companies in that sector.
The key to reducing this fat is monoclonal antibodies, which bind only with a single type of cell.
FibroGen, Inc., South San Francisco, CA, announced it has signed an agreement with the Taisho Pharmaceutical Company, Ltd., Tokyo, Japan, to develop and commercialize human monoclonal antibodies for the treatment of fibrotic kidney diseases.

Full browser ?